Lydia Hickman is a graduate student in the Cook Lab at the University of Birmingham in the United Kingdom. In her Ph.D. work, she explores the fundamental biological mechanisms underlying motor function and social cognition in the context of autism and Parkinson’s disease. Lydia co-founded the U21 Autism Research Network, an international collaboration among six research groups aiming to improve diversity and inclusion in autism research.
Lydia Hickman
Graduate student
University of Birmingham in the United Kingdom
From this contributor
Ways to make autism research more diverse and inclusive
Scientists must focus on the importance of representative study samples and of engaging with diverse autism community members.
Ways to make autism research more diverse and inclusive
Explore more from The Transmitter
‘Push-pull’ recipe for neural wiring used in multiple brain regions
A versatile pair of proteins steers neurons toward their targets and helps establish the brain’s sensory maps, new studies suggest.
‘Push-pull’ recipe for neural wiring used in multiple brain regions
A versatile pair of proteins steers neurons toward their targets and helps establish the brain’s sensory maps, new studies suggest.
Reward-learning algorithm hardwired into dopamine circuit
The finding bolsters the canonical model of reward prediction error, which has come under scrutiny in recent years.
Reward-learning algorithm hardwired into dopamine circuit
The finding bolsters the canonical model of reward prediction error, which has come under scrutiny in recent years.
Exclusive: Brain and spinal cord institute halts research, citing funding problems
The Burke Neurological Institute, which calls itself “the only research institute in the U.S. dedicated to finding treatments to repair the brain and spinal cord,” ceased research operations on 22 May.
Exclusive: Brain and spinal cord institute halts research, citing funding problems
The Burke Neurological Institute, which calls itself “the only research institute in the U.S. dedicated to finding treatments to repair the brain and spinal cord,” ceased research operations on 22 May.